EMBO elects 2024 members

Pedro Beltrao

Mikhail Savitski

Aviv Regev

The European Molecular Biology Organization recently elected 120 new members, including American Society for Biochemistry and Molecular Biology members Pedro Beltrao, Mikhail M. Savitski and Aviv Regev. Beltrao and Savitski were elected as full members, and Regev was elected as an associate member. These scientists were recognized for their research excellence in the life sciences. EMBO will formally welcome the new members at an EMBO meeting in late 2024 in Heidelberg, Germany.

Beltrao is a professor of molecular systems biology at the Swiss Institute of Bioinformatics. His lab develops comprehensive models to study how DNA changes alter biomolecular structure and function and ultimately phenotypic traits or disease. Recently, Beltrao was awarded a Human Frontiers Science Program Research Grant to explore the chemical properties of modified nucleotides and their enzymatic repertoire.

Savitski is a team leader and head of the Proteomics Core Facility at the European Molecular Biology Laboratory. His lab uses and develops stability proteomics methods to understand protein aggregation and disaggregation, cell phenotyping and protein interactions with drugs, metabolites, DNA and RNA. In 2022, he was recognized with an Allen Institute Distinguished Investigator award. 

Regev is the executive vice president and head of Genentech Research and Early Development. Her lab develops and applies experimental methods and computational algorithms to study cells, their intracellular circuits and their interactions in tissues, in both health and disease. Among her many honors are the ASBMB's Earl and Thressa Stadtman award, the Federation of American Societies for Experimental Biology Excellence in Science Award and membership in both the National Academy of Sciences and the National Academy of Medicine. In 2021, she was named a fellow of the American Association for Cancer Research. 

"“The new EMBO members and associate members have made immense contributions to fundamental life science research, and, in many cases, their work has paved the way for innovations that have improved lives and livelihoods around the world,” EMBO Director Fiona Watt said. “I send my warmest congratulations to all those elected.